Indeed, 31% of the values we reported in the last month had the quali1ring comment "specimen received at room temperature" attached to the result. To assess the accuracy of results on these samples, we investigated the stability of FK506 in whole blood at several storage temperatures.
Samples from five inpatients (three heart and two liver recipients) were processed and analyzed for FKSO6 in the routine fashion and then stored at 4 #{176}O for 0 to 5 days. Five samples were then reassayed, divided into aliquota, and stored at the temperatures indicated in Table 1 . An additional eight samples from six patients (one heart, two liver, and three lung recipients) were pooled, and the pool was assayed, divided into aliquots, and stored at the temperatures indicated. No attempt was made to maintain sterility of the specimens. Stored allquota were analyzed by the IMx FK506 assay at the times indicated in Table 1 during the next week. FK506 values did not change during storage at 4 #{176}C from the time of the initial assay until the samples were divided into aliquots. Thereafter, variability over time was generally within the expected precision of the assay. The most recent 30-day quality-control data from our institution indicate the following interrun precision for this assay: CV = 13.1% at a mean value of 15.7 .&g/L, 11.4% at a mean value of 24.6 g/L, and 9.1% at a mean value of 41.8 tg/L. Taken together, these results demonstrate that FK506 is stable for up to 168 h (7 days) at room temperature and for at least 2-3 days at temperatures that may be reached during shipment in the summer months.
We have stopped commenting results for samples received at ambient temperature and feel confident that the results produced from these samples accu-rately reflect in vivo whole-blood FK506 concentrations.
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Various constituents of serum and plasma may simulate the appearance of paraproteins upon electrophoresis. These "pseudoparaproteins" include (1-3) transfernin, C-reactive protein, fibrinogen, genetic variants of proteins (especially transferrin, a1-antitrypsin, and C3), polyclonal increases of immunoglobulin subclasses, haptoglobin-hemoglobin complex in the alpha-2 region, hyperlipemia, increased a2macroglobulin as seen in nephrosis, and products of bacterial contamination.
We recently encountered a patient whose serum, upon serum protein electrophoresis (SPEP), exhibited a band of restricted mobility consistent in appearance with a paraprotein. Upon immunofixation electrophoresis (IFE), however, the sample gave no reactivity with standard immunoglobulin or fibrinogen antisera. We suspected that the band might be related to hemoglobin (Hb) because the specimen was hemolyzed. We confirmed this hypothesis by demonstrating the correspondence of the band to Hb C.
Sera and whole-blood samples (collected into EDTA tubes) from the patient, normal subjects, and subjects with known Hemoglobin Testing System (Bio-Rad Labs., Hercules, CA).
The patient was a 53-year-old black man with a 2-month history of pain in his lower back, bilateral flank, and groin, with anorexia, a weight loss of -8 kg, dyspnea on exertion, and chronic fatigue. Past medical history included a 15-year history of insulindependent diabetes mellitus, hemochromatosis, hepatitis 20 years earlier, and liver biopsy -1 year earlier revealing micronodular cirrhosis. Physical examination was significant for protuberant abdomen, diffuse abdominal tenderness on palpation with guarding, and an enlarged liver. The patient's SPEP results (Fig. 1 ) demonstrate a band of restricted mobility in the near-gamma region. This band corresponded to 6.9% (5.9 g/L) of the total protein concentration of 85.0 g/L. To further characterize the band, we performed IFE with antisera to IgG, IgA, 1gM, kappa and lambda light chains, and fibrinogen;
no reactivity was demonstrated. Examination of sera from the patient obtained 1 day before and 1 and 2 days after the original SPEP specimen was drawn demonstrated no hemolysis in these specimens. This, along with the absence of any indication in the clinical course of an in vivo hemolytic process, suggested in vitro hemolysis. SPEPs were performed on each of the three additional specimens, all of which failed to demonstrate a band of
